C David Sjöström

8PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersTime-series analysisEpidemiological modellingVenereologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 28, 2026
Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis.

|Jan 26, 2026
A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis.

Hiddo J L Heerspink, Dustin J Little, Samvel B Gasparyan

|Oct 23, 2025
Effects of Dapagliflozin on Progression of CKD According to Different Rates of Pretrial eGFR Loss.

Hiddo J L Heerspink, Glenn M Chertow, Peter Rossing

|Oct 30, 2024
Baseline, Early Changes, and Residual Albuminuria: Post Hoc Analysis of a Randomized Clinical Trial of Dapagliflozin in Chronic Kidney Disease.

Dominique van Mil, Priya Vart, Glenn M Chertow

|Apr 02, 2024
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.

Hiddo J L Heerspink, Austin G Stack, Robert Terkeltaub

|Apr 29, 2023
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial.

Glenn M Chertow, Ricardo Correa-Rotter, Priya Vart

Pageof 2

Frequent Collaborators

7 joint publications

Hiddo J L Heerspink

5 joint publications

Glenn M Chertow

5 joint publications

Peter Rossing

4 joint publications

Roberto D Toto